Scarica l'app Stockscreener
7.24
1.43%
-0.10
Precedente Chiudi:
$7.34
Aprire:
$7.49
Volume 24 ore:
3.05M
Relative Volume:
1.25
Capitalizzazione di mercato:
$722.50M
Reddito:
$58.36M
Utile/perdita netta:
$-25.72M
Rapporto P/E:
-19.88
EPS:
-0.3641
Flusso di cassa netto:
$-24.91M
1 W Prestazione:
+8.15%
1M Prestazione:
+48.56%
6M Prestazione:
+189.40%
1 anno Prestazione:
+46.75%
Intervallo 1D:
$7.165
$7.50
Intervallo di 1 settimana:
$6.395
$7.51
Portata 52W:
$2.12
$7.51
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Nome
Aquestive Therapeutics Inc
Settore
Telefono
908-941-1900
Indirizzo
30 TECHNOLOGY DRIVE, WARREN, NJ
Confronta AQST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
7.245 | 832.30M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
143.91 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.91 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.2001 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.78 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
430.14 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2024-12-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-05-10 | Iniziato | Leerink Partners | Outperform |
| 2024-04-11 | Iniziato | Piper Sandler | Overweight |
| 2024-03-28 | Iniziato | Raymond James | Outperform |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-04-22 | Iniziato | H.C. Wainwright | Buy |
| 2019-01-03 | Iniziato | Lake Street | Buy |
| 2018-08-20 | Iniziato | JMP Securities | Mkt Outperform |
| 2018-08-20 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Aquestive Therapeutics Inc Borsa (AQST) Ultime notizie
Can trapped investors hope for a rebound in Aquestive Therapeutics Inc.Market Growth Review & Low Drawdown Investment Ideas - newser.com
Top chart patterns to watch in Aquestive Therapeutics Inc.Quarterly Performance Summary & Daily Volume Surge Signals - newser.com
Real time alert setup for Aquestive Therapeutics Inc. performanceWeekly Profit Report & Expert Approved Trade Ideas - newser.com
Why Aquestive Therapeutics Inc. stock could outperform in 2025July 2025 Sector Moves & High Win Rate Trade Tips - newser.com
Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year? - sharewise.com
Is Aquestive Therapeutics Inc. stock attractive for retirement portfoliosJuly 2025 Catalysts & Fast Exit Strategy with Risk Control - newser.com
Is Aquestive Therapeutics Inc. stock ready for a breakoutWeekly Gains Summary & Free Technical Pattern Based Buy Signals - newser.com
Volatility clustering patterns for Aquestive Therapeutics Inc.July 2025 Final Week & Real-Time Volume Spike Alerts - newser.com
Is Aquestive Therapeutics Inc. reversing from oversold territoryJuly 2025 Market Mood & Safe Entry Momentum Tips - newser.com
Aquestive Therapeutics Stock: A Measured Bet (NASDAQ:AQST) - Seeking Alpha
Aquestive Therapeutics (NASDAQ:AQST) Hits New 12-Month HighShould You Buy? - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Advances Pharma Delivery - Kalkine Media
Aquestive Therapeutics (NASDAQ:AQST) Shares Up 7%Still a Buy? - MarketBeat
Aquestive Therapeutics (AQST) Surges 7.9%: Is This an Indication of Further Gains? - Yahoo Finance
Watching the Narrative for Aquestive Therapeutics Shift After Key Anaphylm Milestones - Yahoo Finance
How to build a dashboard for Aquestive Therapeutics Inc. stockStock Surge & Momentum Based Trading Signals - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for Aquestive Therapeutics (NASDAQ:AQST) - MarketBeat
JMP Securities Maintains Aquestive Therapeutics (AQST) Market Outperform Recommendation - Nasdaq
What high frequency data says about Aquestive Therapeutics Inc.July 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™ - GlobeNewswire
Aquestive Therapeutics Shares Rise After Obtaining 2 New US Patents for Anaphylm Sublingual Film - MarketScreener
Aquestive Therapeutics Obtains 2 New US Patents for Anaphylm Sublingual Film - MarketScreener
Aquestive receives two new patents for oral anaphylaxis treatment By Investing.com - Investing.com Australia
Aquestive receives two new patents for oral anaphylaxis treatment - Investing.com India
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™ - GlobeNewswire Inc.
Signal strength of Aquestive Therapeutics Inc. stock in tech scanners2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com
Why Aquestive Therapeutics Inc. stock is seen as undervaluedWeekly Profit Summary & Community Verified Watchlist Alerts - newser.com
Custom watchlist performance reports with Aquestive Therapeutics Inc.2025 Dividend Review & Free Expert Verified Stock Movement Alerts - newser.com
Statistical indicators supporting Aquestive Therapeutics Inc.’s strengthTrade Analysis Summary & Comprehensive Market Scan Insights - newser.com
Advanced analytics toolkit walkthrough for Aquestive Therapeutics Inc.Portfolio Profit Report & AI Forecast for Swing Trade Picks - newser.com
Aquestive Therapeutics Advances Anaphylm Clinical Development - TipRanks
Aquestive Therapeutics Inc Azioni (AQST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.56%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):